SlideShare a Scribd company logo
Is it time to ban PSA?
In support of OFSA…
Stirling Bryan, PhD
2
Disclosures and Acknowledgements
• I am not aware of any actual or potential conflicts of
interest in relation to this presentation.
• Some of my relevant current activities:
– Chair, CADTH’s Health Technology Expert Review Panel
– Member, CADTH’s Economic Evaluation Guidelines Working
Group
– Member, BC’s Health Technology Assessment Committee
– Director, VCH’s Centre for Clinical Epidemiology & Evaluation
• Collaborators on this topic
– Drs. Pelham Barton and Lazaros Andronis (University of
Birmingham, UK)
3
4
-£400
-£200
£0
£200
£400
£600
£800
£1,000
-0.10 -0.05 0.00 0.05 0.10 0.15 0.20
Incremental QALYs
IncrementalCost
0
0.1
0.2
0.3
0.4
0.5
0.6
0.7
0.8
0.9
1
£0 £10,000 £20,000 £30,000 £40,000 £50,000 £60,000
Willingness to pay per additional QALY
Probabilityofbeingcosteffective
5
6
7
Definitions
• Sensitivity analysis (SA):
– Analysis that aims to assess and determine the influence
of input parameters on the outcomes of an economic
evaluation
• Probabilistic sensitivity analysis (PSA):
– A form of SA in which probability distributions are applied
to input parameters and parameter values drawn at
random from these distributions to generate an empirical
distribution of the relevant measure of cost-effectiveness
• Old-fashioned sensitivity analysis (OFSA):
– A form of sensitivity analysis in which the input
parameters are varied using alternative plausible values
8Bernard et al (2011)
9
The argument…
• The growing influence of economic analyses (at
CADTH, NICE…) emphasises the importance of
methodological rigour
• The appropriate characterisation of uncertainty is
an essential component in economic analysis
• And so…
– Probabilistic analysis (PA) should be the base case
analysis, and so let’s ban PSA!
– OFSA has great value and should be based on PA
10
Review of NICE policy documents
• Many instances where a range of results from
sensitivity analysis was reported
– SA results cited in policy documents come mainly
from OFSAs
• Explicit reference is made in some documents
to the usefulness of the sensitivity analysis,
particularly OFSA
11
Interviews: NICE committee members
• “The most useful thing about the economic analysis is
it focuses the discussion on what actually matters…
What is it that can actually switch a decision…?” [3]
• “The other area… people do struggle with is
uncertainty. And I don’t think anybody quite knows
how to handle cost-effectiveness acceptability curves...
For some people it’s a technical problem of
understanding what they are. For those who
understand what they are, they still don’t understand
what they should do with it.” [4]
12
Conclusions
• Both PA and OFSA have their place
• PSA has no place…
• Effective communication between analysts
and policy makers remains a challenge

More Related Content

PDF
The Portsmouth Lean Journey - Medical Emergeny Value Stream
PPT
Improving Orthopedic Profitability
PPTX
The Innovator's Prescription
PPTX
Cadth 2015 c2 making cost effectiveness analyses more useful
PDF
Cadth symp breakfast 4 Update to Guidelines for the Economic Evaluation of He...
PPT
Cadth 2015 e1 deal prader willi cadth
PPTX
Cadth 2015 e2 dd systemic review-ohtac aug13-2013_2
PPTX
Cadth 2015 e3 eq5 d
The Portsmouth Lean Journey - Medical Emergeny Value Stream
Improving Orthopedic Profitability
The Innovator's Prescription
Cadth 2015 c2 making cost effectiveness analyses more useful
Cadth symp breakfast 4 Update to Guidelines for the Economic Evaluation of He...
Cadth 2015 e1 deal prader willi cadth
Cadth 2015 e2 dd systemic review-ohtac aug13-2013_2
Cadth 2015 e3 eq5 d

More from CADTH Symposium (20)

PPTX
Cadth 2015 e6 husereau rwe cadth
PPT
Cadth 2015 e4 lourenco adaptive design april 2015 final
PPTX
Cadth 2015 e4 fields slides for adaptive panel final
PPTX
Cadth 2015 e4 mcelwee cadth 041415 fnl
PPTX
Cadth 2015 e4 thorlund innovative trial designs in medical decision making
PPT
Cadth 2015 e1 2015 04 cadth v2.0
PPT
Cadth 2015 e4 adaptive design april 2015 final lourenco
PPTX
Cadth symposium 2015 d3 pr os va. generic measures cadth 14th april 2015
PPTX
Cadth 2015 d5 symposium 2015 endonodal trials - version 2
PPT
Cadth 2015 e5 ad panel discussion af
PPTX
Cadth 2015 e5 noac ad symposium_panel_14apr2015
PDF
Cadth 2015 b1 slides allan grill-pcodr-cadth_symposium2015presentationfinal
PPTX
Cadth 2015 breakfast 2 excel hta tools presentation final
PPTX
Cadth 2015 d7 burgess cadth 2015 20150414
PPTX
Cadth 2015 d7 presentation 2015 14 apr15
PPTX
Cadth 2015 d4 lidia engel final
PPTX
Cadth 2015 d2 procurement oral presentation-vf
PPT
Cadth 2015 d6 rn np cadth srna (2)
PPTX
Cadth 2015 e2 miller cadth-ohtac approach-april 14, 2015
PPTX
Cadth 2015 e6 3 brown
Cadth 2015 e6 husereau rwe cadth
Cadth 2015 e4 lourenco adaptive design april 2015 final
Cadth 2015 e4 fields slides for adaptive panel final
Cadth 2015 e4 mcelwee cadth 041415 fnl
Cadth 2015 e4 thorlund innovative trial designs in medical decision making
Cadth 2015 e1 2015 04 cadth v2.0
Cadth 2015 e4 adaptive design april 2015 final lourenco
Cadth symposium 2015 d3 pr os va. generic measures cadth 14th april 2015
Cadth 2015 d5 symposium 2015 endonodal trials - version 2
Cadth 2015 e5 ad panel discussion af
Cadth 2015 e5 noac ad symposium_panel_14apr2015
Cadth 2015 b1 slides allan grill-pcodr-cadth_symposium2015presentationfinal
Cadth 2015 breakfast 2 excel hta tools presentation final
Cadth 2015 d7 burgess cadth 2015 20150414
Cadth 2015 d7 presentation 2015 14 apr15
Cadth 2015 d4 lidia engel final
Cadth 2015 d2 procurement oral presentation-vf
Cadth 2015 d6 rn np cadth srna (2)
Cadth 2015 e2 miller cadth-ohtac approach-april 14, 2015
Cadth 2015 e6 3 brown
Ad

Recently uploaded (20)

PPT
Breast Cancer management for medicsl student.ppt
PPTX
Clinical approach and Radiotherapy principles.pptx
DOC
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
Cardiovascular - antihypertensive medical backgrounds
PDF
Copy of OB - Exam #2 Study Guide. pdf
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
PPTX
History and examination of abdomen, & pelvis .pptx
PPTX
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
PPTX
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
PPTX
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
PPT
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
PPTX
Transforming Regulatory Affairs with ChatGPT-5.pptx
PPTX
Acid Base Disorders educational power point.pptx
PDF
Human Health And Disease hggyutgghg .pdf
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPT
HIV lecture final - student.pptfghjjkkejjhhge
PPTX
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
Breast Cancer management for medicsl student.ppt
Clinical approach and Radiotherapy principles.pptx
Adobe Premiere Pro CC Crack With Serial Key Full Free Download 2025
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
Cardiovascular - antihypertensive medical backgrounds
Copy of OB - Exam #2 Study Guide. pdf
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
MENTAL HEALTH - NOTES.ppt for nursing students
History and examination of abdomen, & pelvis .pptx
DENTAL CARIES FOR DENTISTRY STUDENT.pptx
Human Reproduction: Anatomy, Physiology & Clinical Insights.pptx
Stimulation Protocols for IUI | Dr. Laxmi Shrikhande
STD NOTES INTRODUCTION TO COMMUNITY HEALT STRATEGY.ppt
Transforming Regulatory Affairs with ChatGPT-5.pptx
Acid Base Disorders educational power point.pptx
Human Health And Disease hggyutgghg .pdf
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
HIV lecture final - student.pptfghjjkkejjhhge
anaemia in PGJKKKKKKKKKKKKKKKKHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH...
Ad

Cadth 2015 c2 new methods hta

  • 1. Is it time to ban PSA? In support of OFSA… Stirling Bryan, PhD
  • 2. 2 Disclosures and Acknowledgements • I am not aware of any actual or potential conflicts of interest in relation to this presentation. • Some of my relevant current activities: – Chair, CADTH’s Health Technology Expert Review Panel – Member, CADTH’s Economic Evaluation Guidelines Working Group – Member, BC’s Health Technology Assessment Committee – Director, VCH’s Centre for Clinical Epidemiology & Evaluation • Collaborators on this topic – Drs. Pelham Barton and Lazaros Andronis (University of Birmingham, UK)
  • 3. 3
  • 4. 4 -£400 -£200 £0 £200 £400 £600 £800 £1,000 -0.10 -0.05 0.00 0.05 0.10 0.15 0.20 Incremental QALYs IncrementalCost 0 0.1 0.2 0.3 0.4 0.5 0.6 0.7 0.8 0.9 1 £0 £10,000 £20,000 £30,000 £40,000 £50,000 £60,000 Willingness to pay per additional QALY Probabilityofbeingcosteffective
  • 5. 5
  • 6. 6
  • 7. 7 Definitions • Sensitivity analysis (SA): – Analysis that aims to assess and determine the influence of input parameters on the outcomes of an economic evaluation • Probabilistic sensitivity analysis (PSA): – A form of SA in which probability distributions are applied to input parameters and parameter values drawn at random from these distributions to generate an empirical distribution of the relevant measure of cost-effectiveness • Old-fashioned sensitivity analysis (OFSA): – A form of sensitivity analysis in which the input parameters are varied using alternative plausible values
  • 8. 8Bernard et al (2011)
  • 9. 9 The argument… • The growing influence of economic analyses (at CADTH, NICE…) emphasises the importance of methodological rigour • The appropriate characterisation of uncertainty is an essential component in economic analysis • And so… – Probabilistic analysis (PA) should be the base case analysis, and so let’s ban PSA! – OFSA has great value and should be based on PA
  • 10. 10 Review of NICE policy documents • Many instances where a range of results from sensitivity analysis was reported – SA results cited in policy documents come mainly from OFSAs • Explicit reference is made in some documents to the usefulness of the sensitivity analysis, particularly OFSA
  • 11. 11 Interviews: NICE committee members • “The most useful thing about the economic analysis is it focuses the discussion on what actually matters… What is it that can actually switch a decision…?” [3] • “The other area… people do struggle with is uncertainty. And I don’t think anybody quite knows how to handle cost-effectiveness acceptability curves... For some people it’s a technical problem of understanding what they are. For those who understand what they are, they still don’t understand what they should do with it.” [4]
  • 12. 12 Conclusions • Both PA and OFSA have their place • PSA has no place… • Effective communication between analysts and policy makers remains a challenge